Literature DB >> 782506

Dithranol (anthralin) versus triacetoxyanthracene. Investigations in vitro.

W Raab.   

Abstract

In two in vitro models for evaluating antipsoriatic activity, dithranol (anthralin) and triacetoxyanthracene were compared. Both compounds exhibited an about equal effect on oxygen consumption of surviving human skin. Dithranol, however, exerted a stronger inhibiting effect on glucose-6-phosphate dehydrogenase (-G-6-PDH) activity of human skin homogenates.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 782506     DOI: 10.1111/j.1365-2133.1976.tb00826.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  2 in total

1.  Azaribine (triacetyl-6-azauridine) in psoriasis. Screening by in vitro methods.

Authors:  W Raab; B Gmeiner; P Muckenhuber
Journal:  Arch Dermatol Res       Date:  1977-12-27       Impact factor: 3.017

Review 2.  Steroids versus nonsteroids in the treatment of cutaneous inflammation: therapeutic modalities for office use.

Authors:  E Panconesi; T Lotti
Journal:  Arch Dermatol Res       Date:  1992       Impact factor: 3.017

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.